Top

Published in:

01-02-2021 | Biomarkers | Review Paper

Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases

Authors: Min Li, Yanyan Yang, Zhibin Wang, Tingyu Zong, Xiuxiu Fu, Lynn Htet Htet Aung, Kun Wang, Jian-xun Wang, Tao Yu

Published in: Angiogenesis | Issue 1/2021

Abstract

Cardiovascular diseases (CVDs) are the leading causes of death worldwide. Increasing reports demonstrated that non-coding RNAs (ncRNAs) have been crucially involved in the development of CVDs. Piwi-interacting RNAs (piRNAs) are a novel cluster of small non-coding RNAs with strong uracil bias at the 5′ end and 2′-O-methylation at the 3′ end that are mainly present in the mammalian reproductive system and stem cells and serve as potential modulators of developmental and pathophysiological processes. Recently, piRNAs have been reported to be widely expressed in human tissues and can potentially regulate various diseases. Specifically, concomitant with the development of next-generation sequencing techniques, piRNAs have been found to be differentially expressed in CVDs, indicating their potential involvement in the occurrence and progression of heart diseases. However, the molecular mechanisms and signaling pathways involved with piRNA function have not been fully elucidated. In this review, we present the current understanding of the piRNAs from the perspectives of biogenesis, characteristics, biological function, and regulatory mechanisms, and highlight their potential roles and underlying mechanisms in CVDs, which will provide new insights into the potential applications of piRNAs in the clinical diagnosis, prognosis, and therapeutic strategies for heart diseases.

Shi Q, Yang X (2016) Circulating MicroRNA and long noncoding RNA as biomarkers of cardiovascular diseases. J Cell Physiol 231(4):751–755. https://doi.org/10.1002/jcp.25174CrossRefPubMed

Liu Y, Yang Y, Wang Z, Fu X, Chu X-M, Li Y, Wang Q, He X, Li M, Wang K, Wang J-X, Li P-F, Yu T (2020) Insights into the regulatory role of circRNA in angiogenesis and clinical implications. Atherosclerosis 298:14–26. https://doi.org/10.1016/j.atherosclerosis.2020.02.017CrossRefPubMed

Liu S, Yang Y, Jiang S, Xu H, Tang N, Lobo A, Zhang R, Liu S, Yu T, Xin H (2019) MiR-378a-5p regulates proliferation and migration in vascular smooth muscle cell by targeting CDK1. Front Genet 10:22. https://doi.org/10.3389/fgene.2019.00022CrossRefPubMedPubMedCentral

Tang N, Jiang S, Yang Y, Liu S, Ponnusamy M, Xin H, Yu T (2018) Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus. Cardiovasc Ther 36(4):e12436. https://doi.org/10.1111/1755-5922.12436CrossRefPubMed

Zeng Y, Du WW, Wu Y, Yang Z, Awan FM, Li X, Yang W, Zhang C, Yang Q, Yee A, Chen Y, Yang F, Sun H, Huang R, Yee AJ, Li R-K, Wu Z, Backx PH, Yang BB (2017) A circular RNA binds to and activates AKT phosphorylation and nuclear localization reducing apoptosis and enhancing cardiac repair. Theranostics 7(16):3842–3855. https://doi.org/10.7150/thno.19764CrossRefPubMedPubMedCentral

Sharma AK, Nelson MC, Brandt JE, Wessman M, Mahmud N, Weller KP, Hoffman R (2001) Human CD34(+) stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood 97(2):426–434CrossRef

Girard A, Sachidanandam R, Hannon GJ, Carmell MA (2006) A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature 442(7099):199–202. https://doi.org/10.1038/nature04917CrossRefPubMed

Perera BPU, Tsai ZT-Y, Colwell ML, Jones TR, Goodrich JM, Wang K, Sartor MA, Faulk C, Dolinoy DC (2019) Somatic expression of piRNA and associated machinery in the mouse identifies short, tissue-specific piRNA. Epigenetics 14(5):504–521. https://doi.org/10.1080/15592294.2019.1600389CrossRefPubMedPubMedCentral

Roy J, Sarkar A, Parida S, Ghosh Z, Mallick B (2017) Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis. Mol Biosyst 13(3):565–576. https://doi.org/10.1039/c6mb00699jCrossRefPubMed

10.

Lee EJ, Banerjee S, Zhou H, Jammalamadaka A, Arcila M, Manjunath BS, Kosik KS (2011) Identification of piRNAs in the central nervous system. RNA 17(6):1090–1099. https://doi.org/10.1261/rna.2565011CrossRefPubMedPubMedCentral

11.

Moyano M, Stefani G (2015) piRNA involvement in genome stability and human cancer. J Hematol Oncol 8:38. https://doi.org/10.1186/s13045-015-0133-5CrossRefPubMedPubMedCentral

12.

Rajan KS, Velmurugan G, Pandi G, Ramasamy S (2014) miRNA and piRNA mediated Akt pathway in heart: antisense expands to survive. Int J Biochem Cell Biol 55:153–156. https://doi.org/10.1016/j.biocel.2014.09.001CrossRefPubMed

13.

Lipps C, Northe P, Figueiredo R, Rohde M, Brahmer A, Krämer-Albers E-M, Liebetrau C, Wiedenroth CB, Mayer E, Kriechbaum SD, Dörr O, Nef H, Hamm CW, Keller T, Troidl C (2019) Non-invasive approach for evaluation of pulmonary hypertension using extracellular vesicle-associated small non-coding RNA. Biomolecules. https://doi.org/10.3390/biom9110666CrossRefPubMedPubMedCentral

14.

Rajan KS, Velmurugan G, Gopal P, Ramprasath T, Babu DDV, Krithika S, Jenifer YC, Freddy A, William G, Kalpana K, Ramasamy S (2016) Abundant and altered expression of PIWI-interacting RNAs during cardiac hypertrophy. Heart Lung Circ 25(10):1013–1020. https://doi.org/10.1016/j.hlc.2016.02.015CrossRefPubMed

15.

Vella S, Gallo A, Lo Nigro A, Galvagno D, Raffa GM, Pilato M, Conaldi PG (2016) PIWI-interacting RNA (piRNA) signatures in human cardiac progenitor cells. Int J Biochem Cell Biol. https://doi.org/10.1016/j.biocel.2016.04.012CrossRefPubMed

16.

Li Y, Zeng A, Li G, Guan Y-N, Yang H-T, Shen B, Jing Q (2017) Dynamic regulation of small RNAome during the early stage of cardiac differentiation from pluripotent embryonic stem cells. Genom Data 12:136–145. https://doi.org/10.1016/j.gdata.2017.05.006CrossRefPubMedPubMedCentral

17.

Yang J, Xue FT, Li YY, Liu W, Zhang S (2018) Exosomal piRNA sequencing reveals differences between heart failure and healthy patients. Eur Rev Med Pharmacol Sci 22(22):7952–7961. https://doi.org/10.26355/eurrev_201811_16423CrossRefPubMed

18.

Izumi N, Shoji K, Suzuki Y, Katsuma S, Tomari Y (2020) Zucchini consensus motifs determine the mechanism of pre-piRNA production. Nature 578(7794):311–316. https://doi.org/10.1038/s41586-020-1966-9CrossRefPubMed

19.

Cheng Y, Wang Q, Jiang W, Bian Y, Zhou Y, Gou A, Zhang W, Fu K, Shi W (2019) Emerging roles of piRNAs in cancer: challenges and prospects. Aging (Albany NY) 11(21):9932–9946. https://doi.org/10.18632/aging.102417CrossRef

20.

Rajan KS, Ramasamy S (2014) Retrotransposons and piRNA: the missing link in central nervous system. Neurochem Int. https://doi.org/10.1016/j.neuint.2014.05.017CrossRefPubMed

21.

Mao Y, Qian S-B (2020) Ribosome-guided piRNA production. Nat Cell Biol 22(2):141–142. https://doi.org/10.1038/s41556-020-0464-5CrossRefPubMed

22.

Sun YH, Zhu J, Xie LH, Li Z, Meduri R, Zhu X, Song C, Chen C, Ricci EP, Weng Z, Li XZ (2020) Ribosomes guide pachytene piRNA formation on long intergenic piRNA precursors. Nat Cell Biol 22(2):200–212. https://doi.org/10.1038/s41556-019-0457-4CrossRefPubMed

23.

Iwasaki YW, Siomi MC, Siomi H (2015) PIWI-interacting RNA: its biogenesis and functions. Annu Rev Biochem 84:405–433. https://doi.org/10.1146/annurev-biochem-060614-034258CrossRefPubMed

24.

Houwing S, Kamminga LM, Berezikov E, Cronembold D, Girard A, van den Elst H, Filippov DV, Blaser H, Raz E, Moens CB, Plasterk RHA, Hannon GJ, Draper BW, Ketting RF (2007) A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish. Cell 129(1):69–82CrossRef

25.

Freedman JE, Gerstein M, Mick E, Rozowsky J, Levy D, Kitchen R, Das S, Shah R, Danielson K, Beaulieu L, Navarro FCP, Wang Y, Galeev TR, Holman A, Kwong RY, Murthy V, Tanriverdi SE, Koupenova-Zamor M, Mikhalev E, Tanriverdi K (2016) Diverse human extracellular RNAs are widely detected in human plasma. Nat Commun 7:11106. https://doi.org/10.1038/ncomms11106CrossRefPubMedPubMedCentral

26.

Ohara T, Sakaguchi Y, Suzuki T, Ueda H, Miyauchi K, Suzuki T (2007) The 3′ termini of mouse Piwi-interacting RNAs are 2′-O-methylated. Nat Struct Mol Biol 14(4):349–350CrossRef

27.

Yamaguchi S, Oe A, Nishida KM, Yamashita K, Kajiya A, Hirano S, Matsumoto N, Dohmae N, Ishitani R, Saito K, Siomi H, Nishimasu H, Siomi MC, Nureki O (2020) Crystal structure of Drosophila Piwi. Nat Commun 11(1):858. https://doi.org/10.1038/s41467-020-14687-1CrossRefPubMedPubMedCentral

28.

Gainetdinov I, Colpan C, Arif A, Cecchini K, Zamore PD (2018) A single mechanism of biogenesis, initiated and directed by PIWI proteins, explains piRNA production in most animals. Mol Cell. https://doi.org/10.1016/j.molcel.2018.08.007CrossRefPubMedPubMedCentral

29.

Nagamori I, Kobayashi H, Nishimura T, Yamagishi R, Katahira J, Kuramochi-Miyagawa S, Kono T, Nakano T (2018) Relationship between PIWIL4-mediated H3K4me2 demethylation and piRNA-dependent DNA methylation. Cell Rep 25(2):350–356. https://doi.org/10.1016/j.celrep.2018.09.017CrossRefPubMed

30.

Schulze M, Sommer A, Plötz S, Farrell M, Winner B, Grosch J, Winkler J, Riemenschneider MJ (2018) Sporadic Parkinson's disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs. Acta Neuropathol Commun 6(1):58. https://doi.org/10.1186/s40478-018-0561-xCrossRefPubMedPubMedCentral

31.

Qiu W, Guo X, Lin X, Yang Q, Zhang W, Zhang Y, Zuo L, Zhu Y, Li C-SR, Ma C, Luo X (2017) Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease. Neurobiol Aging 57:170–177. https://doi.org/10.1016/j.neurobiolaging.2017.05.020CrossRefPubMedPubMedCentral

32.

Guo B, Li D, Du L, Zhu X (2020) piRNAs: biogenesis and their potential roles in cancer. Cancer Metastasis Rev. https://doi.org/10.1007/s10555-020-09863-0CrossRefPubMed

33.

Das B, Jain N, Mallick B (2020) piR-39980 promotes cell proliferation, migration and invasion, and inhibits apoptosis via repression of SERPINB1 in human osteosarcoma. Biol Cell 112(3):73–91. https://doi.org/10.1111/boc.201900063CrossRefPubMed

34.

Zhang L, Meng X, Pan C, Qu F, Gan W, Xiang Z, Han X, Li D (2020) piR-31470 epigenetically suppresses the expression of glutathione S-transferase pi 1 in prostate cancer via DNA methylation. Cell Signal 67:109501. https://doi.org/10.1016/j.cellsig.2019.109501CrossRefPubMed

35.

Manakov SA, Pezic D, Marinov GK, Pastor WA, Sachidanandam R, Aravin AA (2015) MIWI2 and MILI have differential effects on piRNA biogenesis and DNA methylation. Cell Rep 12(8):1234–1243. https://doi.org/10.1016/j.celrep.2015.07.036CrossRefPubMedPubMedCentral

36.

Kojima-Kita K, Kuramochi-Miyagawa S, Nagamori I, Ogonuki N, Ogura A, Hasuwa H, Akazawa T, Inoue N, Nakano T (2016) MIWI2 as an effector of DNA methylation and gene silencing in embryonic male germ cells. Cell Rep 16(11):2819–2828. https://doi.org/10.1016/j.celrep.2016.08.027CrossRefPubMed

37.

Watanabe T, Cui X, Yuan Z, Qi H, Lin H (2018) MIWI2 targets RNAs transcribed from piRNA-dependent regions to drive DNA methylation in mouse prospermatogonia. EMBO J. https://doi.org/10.15252/embj.201695329CrossRefPubMedPubMedCentral

38.

Zhang H, Gao Q, Tan S, You J, Lyu C, Zhang Y, Han M, Chen Z, Li J, Wang H, Liao L, Qin J, Li J, Wong J (2019) SET8 prevents excessive DNA methylation by methylation-mediated degradation of UHRF1 and DNMT1. Nucleic Acids Res 47(17):9053–9068. https://doi.org/10.1093/nar/gkz626CrossRefPubMedPubMedCentral

39.

Dong J, Wang X, Cao C, Wen Y, Sakashita A, Chen S, Zhang J, Zhang Y, Zhou L, Luo M, Liu M, Liao A, Namekawa SH, Yuan S (2019) UHRF1 suppresses retrotransposons and cooperates with PRMT5 and PIWI proteins in male germ cells. Nat Commun 10(1):4705. https://doi.org/10.1038/s41467-019-12455-4CrossRefPubMedPubMedCentral

40.

Vaughan RM, Rothbart SB, Dickson BM (2019) The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation. J Biol Chem 294(43):15724–15732. https://doi.org/10.1074/jbc.RA119.010160CrossRefPubMedPubMedCentral

41.

Su J-F, Zhao F, Gao Z-W, Hou Y-J, Li Y-Y, Duan L-J, Lun S-M, Yang H-J, Li J-K, Dai N-T, Shen F-F, Zhou F-Y (2020) piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B. Pathol Res Pract. https://doi.org/10.1016/j.prp.2020.152848CrossRefPubMed

42.

Zhang C, Sha H, Peng Y, Wang Y, Liu C, Zhou X (2019) PiRNA-DQ541777 contributes to neuropathic pain via targeting Cdk5rap1. J Neurosci 39(45):9028–9039. https://doi.org/10.1523/JNEUROSCI.1602-19.2019CrossRefPubMedPubMedCentral

43.

Holoch D, Moazed D (2015) RNA-mediated epigenetic regulation of gene expression. Nat Rev Genet 16(2):71–84. https://doi.org/10.1038/nrg3863CrossRefPubMedPubMedCentral

44.

Sienski G, Batki J, Senti K-A, Dönertas D, Tirian L, Meixner K, Brennecke J (2015) Silencio/CG9754 connects the Piwi-piRNA complex to the cellular heterochromatin machinery. Genes Dev 29(21):2258–2271. https://doi.org/10.1101/gad.271908.115CrossRefPubMedPubMedCentral

45.

Yu Y, Gu J, Jin Y, Luo Y, Preall JB, Ma J, Czech B, Hannon GJ (2015) Panoramix enforces piRNA-dependent cotranscriptional silencing. Science 350(6258):339–342. https://doi.org/10.1126/science.aab0700CrossRefPubMedPubMedCentral

46.

Ninova M, Chen Y-CA, Godneeva B, Rogers AK, Luo Y, Fejes Tóth K, Aravin AA (2020) Su(var)2–10 and the SUMO pathway link piRNA-guided target recognition to chromatin silencing. Mol Cell. https://doi.org/10.1016/j.molcel.2019.11.012CrossRefPubMed

47.

Wolf G, Greenberg D, Macfarlan TS (2015) Spotting the enemy within: targeted silencing of foreign DNA in mammalian genomes by the Krüppel-associated box zinc finger protein family. Mob DNA 6:17. https://doi.org/10.1186/s13100-015-0050-8CrossRefPubMedPubMedCentral

48.

Osumi K, Sato K, Murano K, Siomi H, Siomi MC (2019) Essential roles of Windei and nuclear monoubiquitination of Eggless/SETDB1 in transposon silencing. EMBO Rep 20(12):e48296. https://doi.org/10.15252/embr.201948296CrossRefPubMedPubMedCentral

49.

Stein P, Rozhkov NV, Li F, Cárdenas FL, Davydenko O, Davydenk O, Vandivier LE, Gregory BD, Hannon GJ, Schultz RM (2015) Essential role for endogenous siRNAs during meiosis in mouse oocytes. PLoS Genet 11(2):e1005013. https://doi.org/10.1371/journal.pgen.1005013CrossRefPubMedPubMedCentral

50.

Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, Hodges E, Anger M, Sachidanandam R, Schultz RM, Hannon GJ (2008) Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 453(7194):534–538. https://doi.org/10.1038/nature06904CrossRefPubMedPubMedCentral

51.

Taborska E, Pasulka J, Malik R, Horvat F, Jenickova I, Jelić Matošević Z, Svoboda P (2019) Restricted and non-essential redundancy of RNAi and piRNA pathways in mouse oocytes. PLoS Genet 15(12):e1008261. https://doi.org/10.1371/journal.pgen.1008261CrossRefPubMedPubMedCentral

52.

Yamashiro H, Negishi M, Kinoshita T, Ishizu H, Ohtani H, Siomi MC (2020) Armitage determines Piwi-piRISC processing from precursor formation and quality control to inter-organelle translocation. EMBO Rep 21(2):e48769. https://doi.org/10.15252/embr.201948769CrossRefPubMed

53.

Ishizu H, Kinoshita T, Hirakata S, Komatsuzaki C, Siomi MC (2019) Distinct and collaborative functions of Yb and armitage in transposon-targeting piRNA biogenesis. Cell Rep. https://doi.org/10.1016/j.celrep.2019.04.029CrossRefPubMed

54.

Kordyukova M, Sokolova O, Morgunova V, Ryazansky S, Akulenko N, Glukhov S, Kalmykova A (2020) Nuclear Ccr4-Not mediates the degradation of telomeric and transposon transcripts at chromatin in the Drosophila germline. Nucleic Acids Res 48(1):141–156. https://doi.org/10.1093/nar/gkz1072CrossRefPubMed

55.

Dai P, Wang X, Gou L-T, Li Z-T, Wen Z, Chen Z-G, Hua M-M, Zhong A, Wang L, Su H, Wan H, Qian K, Liao L, Li J, Tian B, Li D, Fu X-D, Shi H-J, Zhou Y, Liu M-F (2019) A translation-activating function of MIWI/piRNA during mouse spermiogenesis. Cell. https://doi.org/10.1016/j.cell.2019.11.022CrossRefPubMedPubMedCentral

56.

Ophinni Y, Palatini U, Hayashi Y, Parrish NF (2019) piRNA-guided CRISPR-like immunity in eukaryotes. Trends Immunol. https://doi.org/10.1016/j.it.2019.09.003CrossRefPubMed

57.

Yu T, Koppetsch BS, Pagliarani S, Johnston S, Silverstein NJ, Luban J, Chappell K, Weng Z, Theurkauf WE (2019) The piRNA response to retroviral invasion of the koala genome. Cell. https://doi.org/10.1016/j.cell.2019.09.002CrossRefPubMedPubMedCentral

58.

Mao Q, Fan L, Wang X, Lin X, Cao Y, Zheng C, Zhang Y, Zhang H, Garcia-Milian R, Kang L, Shi J, Yu T, Wang K, Zuo L, Li C-SR, Guo X, Luo X (2019) Transcriptome-wide piRNA profiling in human brains for aging genetic factors. Jacobs J Genet 4(1):14

59.

Mai D, Ding P, Tan L, Zhang J, Pan Z, Bai R, Li C, Li M, Zhou Y, Tan W, Zhou Z, Li Y, Zhou A, Ye Y, Pan L, Zheng Y, Su J, Zuo Z, Liu Z, Zhao Q, Li X, Huang X, Li W, Wu S, Jia W, Zou S, Wu C, Xu R-H, Zheng J, Lin D (2018) PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma. Theranostics 8(19):5213–5230. https://doi.org/10.7150/thno.28001CrossRefPubMedPubMedCentral

60.

Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H, Tao J, Li W, Yin X, Xu W (2019) The emerging role of the piRNA/piwi complex in cancer. Mol Cancer 18(1):123. https://doi.org/10.1186/s12943-019-1052-9CrossRefPubMedPubMedCentral

61.

Ai L, Mu S, Sun C, Fan F, Yan H, Qin Y, Cui G, Wang Y, Guo T, Mei H, Wang H, Hu Y (2019) Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation. Mol Cancer 18(1):88. https://doi.org/10.1186/s12943-019-1011-5CrossRefPubMedPubMedCentral

62.

Liu Y, Li G, Lu H, Li W, Li X, Liu H, Li X, Li T, Yu B (2014) Expression profiling and ontology analysis of long noncoding RNAs in post-ischemic heart and their implied roles in ischemia/reperfusion injury. Gene 543(1):15–21. https://doi.org/10.1016/j.gene.2014.04.016CrossRefPubMed

63.

Wang J-X, Zhang X-J, Li Q, Wang K, Wang Y, Jiao J-Q, Feng C, Teng S, Zhou L-Y, Gong Y, Zhou Z-X, Liu J, Wang J-L, Li P-f (2015) MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD. Circ Res 117(4):352–363. https://doi.org/10.1161/CIRCRESAHA.117.305781CrossRefPubMed

64.

Zhao LY, Zhang J, Guo B, Yang J, Han J, Zhao XG, Wang XF, Liu LY, Li ZF, Song TS, Huang C (2013) MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells. Cell Mol Biol (Noisy-le-grand) 59:OL1876–OL1881

65.

Law PTY, Qin H, Ching AKK, Lai KP, Co NN, He M, Lung RWM, Chan AWH, Chan T-F, Wong N (2013) Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma. J Hepatol 58(6):1165–1173. https://doi.org/10.1016/j.jhep.2013.01.032CrossRefPubMed

66.

Duan L, Hu J, Xiong X, Liu Y, Wang J (2018) The role of DNA methylation in coronary artery disease. Gene 646:91–97. https://doi.org/10.1016/j.gene.2017.12.033CrossRefPubMed

67.

Kızıltunç E, Kösem A, Özkan C, Ilgın BU, Kundi H, Çetin M, Ornek E (2019) Serum sirtuin 1, 3 and 6 levels in acute myocardial infarction patients. Arq Bras Cardiol 113(1):33–39. https://doi.org/10.5935/abc.20190114CrossRefPubMedPubMedCentral

68.

Ottaviani L, da Costa Martins PA (2017) Non-coding RNAs in cardiac hypertrophy. J Physiol (Lond) 595(12):4037–4050. https://doi.org/10.1113/JP273129CrossRef

69.

Peng L, Song L, Liu C, Lv X, Li X, Jie J, Zhao D, Li D (2016) piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signaling. Tumour Biol 37(2):2749–2756. https://doi.org/10.1007/s13277-015-4056-0CrossRefPubMed

70.

Qi H, Ren J, Ba L, Song C, Zhang Q, Cao Y, Shi P, Fu B, Liu Y, Sun H (2020) MSTN attenuates cardiac hypertrophy through inhibition of excessive cardiac autophagy by blocking AMPK /mTOR and miR-128/PPARγ/NF-κB. Mol Ther Nucleic Acids 19:507–522. https://doi.org/10.1016/j.omtn.2019.12.003CrossRefPubMed

71.

Crippa S, Nemir M, Ounzain S, Ibberson M, Berthonneche C, Sarre A, Boisset G, Maison D, Harshman K, Xenarios I, Diviani D, Schorderet D, Pedrazzini T (2016) Comparative transcriptome profiling of the injured zebrafish and mouse hearts identifies miRNA-dependent repair pathways. Cardiovasc Res 110(1):73–84. https://doi.org/10.1093/cvr/cvw031CrossRefPubMedPubMedCentral

72.

Chong ZZ, Shang YC, Maiese K (2011) Cardiovascular disease and mTOR signaling. Trends Cardiovasc Med 21(5):151–155. https://doi.org/10.1016/j.tcm.2012.04.005CrossRefPubMedPubMedCentral

73.

Pipicz M, Demján V, Sárközy M, Csont T (2018) Effects of cardiovascular risk factors on cardiac STAT3. Int J Mol Sci. https://doi.org/10.3390/ijms19113572CrossRefPubMedPubMedCentral

74.

Aplin AC, Nicosia RF (2019) The plaque-aortic ring assay: a new method to study human atherosclerosis-induced angiogenesis. Angiogenesis 22(3):421–431. https://doi.org/10.1007/s10456-019-09667-zCrossRefPubMed

75.

Wu Q, Xu W-D, Huang A-F (2020) Role of angiopoietin-2 in inflammatory autoimmune diseases: a comprehensive review. Int Immunopharmacol 80:106223. https://doi.org/10.1016/j.intimp.2020.106223CrossRefPubMed

76.

Xian D, Song J, Yang L, Xiong X, Lai R, Zhong J (2019) Emerging roles of redox-mediated angiogenesis and oxidative stress in dermatoses. Oxid Med Cell Longev 2019:2304018. https://doi.org/10.1155/2019/2304018CrossRefPubMedPubMedCentral

77.

Cheng J, Guo J-M, Xiao B-X, Miao Y, Jiang Z, Zhou H, Li Q-N (2011) piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 412(17–18):1621–1625. https://doi.org/10.1016/j.cca.2011.05.015CrossRefPubMed

78.

Cheng J, Deng H, Xiao B, Zhou H, Zhou F, Shen Z, Guo J (2012) piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett 315(1):12–17. https://doi.org/10.1016/j.canlet.2011.10.004CrossRefPubMed

79.

Yan H, Wu QL, Sun CY, Ai LS, Deng J, Zhang L, Chen L, Chu ZB, Tang B, Wang K, Wu XF, Xu J, Hu Y (2015) piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma. Leukemia 29(1):196–206. https://doi.org/10.1038/leu.2014.135CrossRefPubMed

80.

Li B, Hong J, Hong M, Wang Y, Yu T, Zang S, Wu Q (2019) piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment. Oncogene 38(26):5227–5238. https://doi.org/10.1038/s41388-019-0788-4CrossRefPubMed

81.

Zhang X, Huang F, Li W, Dang J-L, Yuan J, Wang J, Zeng D-L, Sun C-X, Liu Y-Y, Ao Q, Tan H, Su W, Qian X, Olsen N, Zheng SG (2018) Human gingiva-derived mesenchymal stem cells modulate monocytes/macrophages and alleviate atherosclerosis. Front Immunol 9:878. https://doi.org/10.3389/fimmu.2018.00878CrossRefPubMedPubMedCentral

82.

Zhang X, Huang F, Chen Y, Qian X, Zheng SG (2016) Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis. Am J Transl Res 8(10):4017–4024PubMedPubMedCentral

83.

Li J, Xue H, Li T, Chu X, Xin D, Xiong Y, Qiu W, Gao X, Qian M, Xu J, Wang Z, Li G (2019) Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE mice via miR-let7 mediated infiltration and polarization of M2 macrophage. Biochem Biophys Res Commun 510(4):565–572. https://doi.org/10.1016/j.bbrc.2019.02.005CrossRefPubMed

84.

Moghaddam AS, Afshari JT, Esmaeili S-A, Saburi E, Joneidi Z, Momtazi-Borojeni AA (2019) Cardioprotective microRNAs: lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease. Atherosclerosis 285:1–9. https://doi.org/10.1016/j.atherosclerosis.2019.03.016CrossRefPubMed

85.

Xing X, Li Z, Yang X, Li M, Liu C, Pang Y, Zhang L, Li X, Liu G, Xiao Y (2020) Adipose-derived mesenchymal stem cells-derived exosome-mediated microRNA-342-5p protects endothelial cells against atherosclerosis. Aging (Albany NY) 12(4):3880–3898. https://doi.org/10.18632/aging.102857CrossRef

86.

Liu S, Yang Y, Jiang S, Tang N, Tian J, Ponnusamy M, Tariq MA, Lian Z, Xin H, Yu T (2018) Understanding the role of non-coding RNA (ncRNA) in stent restenosis. Atherosclerosis 272:153–161. https://doi.org/10.1016/j.atherosclerosis.2018.03.036CrossRefPubMed

87.

Li M, Ding W, Tariq MA, Chang W, Zhang X, Xu W, Hou L, Wang Y, Wang J (2018) A circular transcript of gene mediates ischemic myocardial injury by targeting miR-133a-3p. Theranostics 8(21):5855–5869. https://doi.org/10.7150/thno.27285CrossRefPubMedPubMedCentral

88.

Yang Y, Yu T, Jiang S, Zhang Y, Li M, Tang N, Ponnusamy M, Wang J-X, Li P-F (2017) miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204. Expert Opin Ther Pat 27(9):1021–1029. https://doi.org/10.1080/13543776.2017.1344217CrossRefPubMed

89.

Bei Y, Yang T, Wang L, Holvoet P, Das S, Sluijter JPG, Monteiro MC, Liu Y, Zhou Q, Xiao J (2018) Circular RNAs as potential theranostics in the cardiovascular system. Mol Ther Nucleic Acids 13:407–418. https://doi.org/10.1016/j.omtn.2018.09.022CrossRefPubMedPubMedCentral

90.

Mompeón A, Ortega-Paz L, Vidal-Gómez X, Costa TJ, Pérez-Cremades D, Garcia-Blas S, Brugaletta S, Sanchis J, Sabate M, Novella S, Dantas AP, Hermenegildo C (2020) Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis. Sci Rep 10(1):5373. https://doi.org/10.1038/s41598-020-61507-zCrossRefPubMedPubMedCentral

91.

Wen P, Song D, Ye H, Wu X, Jiang L, Tang B, Zhou Y, Fang L, Cao H, He W, Yang Y, Dai C, Yang J (2014) Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients. PLoS ONE 9(10):e103079. https://doi.org/10.1371/journal.pone.0103079CrossRefPubMedPubMedCentral

92.

Aravin A, Gaidatzis D, Pfeffer S, Lagos-Quintana M, Landgraf P, Iovino N, Morris P, Brownstein MJ, Kuramochi-Miyagawa S, Nakano T, Chien M, Russo JJ, Ju J, Sheridan R, Sander C, Zavolan M, Tuschl T (2006) A novel class of small RNAs bind to MILI protein in mouse testes. Nature 442(7099):203–207CrossRef

Title: Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases
Authors: Min Li
Yanyan Yang
Zhibin Wang
Tingyu Zong
Xiuxiu Fu
Lynn Htet Htet Aung
Kun Wang
Jian-xun Wang
Tao Yu
Publication date: 01-02-2021
Publisher: Springer Netherlands
Keyword: Biomarkers
Published in: Angiogenesis / Issue 1/2021
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI: https://doi.org/10.1007/s10456-020-09750-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway

Protection of capillaries may be critical in delaying aging around the eyes and prevention of facial plastic surgery

Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors

Talin-dependent integrin activation is required for endothelial proliferation and postnatal angiogenesis

BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF

AgeR deletion decreases soluble fms-like tyrosine kinase 1 production and improves post-ischemic angiogenesis in uremic mice

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage